Portland, OR - November 18, 2017

4th Annual Melanoma Patient Symposium

(Co-hosted by OHSU Department of Dermatology & SolSurvivors Oregon)

Date: Saturday – November 18, 2017
Time:  8:00am – 1:00pm PST
OHSU School of Nursing
3455 SW US Veterans
Hospital Rd.
Portland, OR 97239

Free parking will be available at 800 SW Gaines St., Lot #60. There will be signage reading “Patient Research Symposium.”

Presenters and Topics



Registration, Bagels and Coffee


Patient Welcome Introduction
Sol Survivors' Introduction


Explanation of Table Topics

8:15am - 9:35am

8:15am - Rotate to 1st topic

8:20am - 1st topic begins

8:45am - Rotate to 2nd topic

8:50am - 2nd topic begins

9:15am - Rotate to 3rd topic

9:20am - 3rd topic begins

Small Table Group Discussions:

• Psychosocial Impacts for Melanoma Survivors - Led by: Katie Hennessy

• Sol Survivors Why YOU Should Join Us - Led by: Shon Ramey, Bob Weir

• Phone Apps and AI, What’s Next? - Led by: Tracy Petrie, Kelly Nelson, MD

• UV Exposure = DNA Damage, What Are Scientists Exploring to Prevent It? - Led by: Amanda McCullough

• Why Clinical Trials May Be the Key That Unlocks the Answers - Led by: Curti Urba, MD

• War on Melanoma Community Outreach - Led by: Sancy Leachman, MD


File in for Keynote
Coffee available


CME Welcome Remarks
Intro to the Virtual Melanoma Tumor Board & Educational Updates
Oliver Wisco, MD


Keynote Speech
Artificial Intelligence and Melanoma Diagnosis: Are Dermatologists Out of a Job?
Kelly Nelson, MD
MD Anderson Cancer Center


Q&A with Keynote


OHSU Dermatology Melanoma Therapy/Research/Program Update
Sancy Leachman, MD


Surgical Oncology Melanoma Therapy Update
John Vetto, MD


Providence’s Melanoma Therapy Update
Brendan Curti, MD


In-Person and Online Participant Discussion Q&A with CME Speakers


Closing Comments & Questions

Other Information

If you have any questions, please email sguild@AIMatMelanoma.org.

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.